The Post first wrote about Violet Law in May when her family was raising money for medical research. Recently, she qualified for a clinical trial into treatments for GM1 gangliosidosis.
The Post first wrote about Violet Law in May when her family was raising money for medical research. Recently, she qualified for a clinical trial into treatments for GM1 gangliosidosis.